Background: Evidence shows that long non-coding RNAs (lncRNAs) are involved in individual development, cell differentiation, cell cycle processes and other important life processes and are closely related to major human diseases, including diabetes. Recent studies have reported that lncRNAs are involved in β cell functions and that lncRNA Gas5 levels decreased in T2DM patients' serum. The purpose of this study was to clarify the role of lncRNA Gas5 in mouse β cell functions in vitro and in vivo. Methods: lncRNA Gas5 expression in T2DM and normal mouse tissues was analyzed using qRT-PCR. RNAi, qRT-PCR, Annexin V-FITC assays, western blot, GSIS and RIA were performed to detect the effects of lncRNA Gas5 on insulin synthesis and secretion in vitro and in vivo. Results: The lncRNA Gas5 level was significantly decreased in db/db mice. However, lncRNA Gas5 expression was relatively high in the pancreas of normal mice. Knockdown of lncRNA Gas5 expression led to cell cycle G1 arrest and impaired insulin synthesis and secretion in Min6 cells. Further, knockdown of lncRNA Gas5 expression in primary isolated islets resulted in decreased expression of insulin gene and transcription factors, Pdx1 and MafA. These results indicate that lncRNA Gas5 might perform as a new regulator, maintaining β cell identity and function by affecting insulin synthesis and secretion.
Introduction
Pancreatic β cells play an important role in maintaining regulation of blood glucose levels because they are the only cell type that can synthesize and secrete insulin in the body [1] . Many studies have found that transcription factors and microRNAs are essential for β cell development and function. Their abnormal expression might be related to islet function damage and development of diabetes [2, 3] . However, studies investigating links between long noncoding RNAs (lncRNAs), pancreatic β cell function, and the development of diabetes have just started.
Noncoding RNA (ncRNA) includes short RNA, such as miRNA, siRNA and piRNA, and long noncoding RNA (lncRNA) [4] . There is no strict limit between short RNA and lncRNA, but the length of the ncRNA nucleotide sequence distinguishes them. In recent years, many studies have shown that lncRNAs regulate protein-coding genes at epigenetic, transcriptional and post-transcription levels and are involved in transcription activation, transcription interference, transcription regulation, and other important regulation processes [4, 5] . lncRNAs are also involved in regulating various processes related to cancer, diabetes, autoimmune diseases and Alzheimer's disease [4] . lncRNA H19 was first reported to be involved in intergenerational transfer of gestational diabetes mellitus (GDM) and in GDM-associated impairments of islet structure and function [6] . Jorge Ferrer [7] and others identified 1128 lncRNAs from human adult islet cells and showed that islet-related lncRNAs were highly specific and subject to the regulation of glucose. Previous studies [8, 9] have shown that knockdown of lncRNA TUG1 expression in vivo and in vitro affected apoptosis of islet β cells and insulin secretion. lncRNA Meg3 levels were significantly decreased in NOD mice and db/db mice islets, and knockdown of lncRNA Meg3 expression, in vivo and in vitro, affected islet β cell synthesis and secretion of insulin and increased β cell apoptosis. β-cell long intergenic non-coding RNA 1 (βlinc1) is necessary for the specification and function of islet β cells. Knockdown of βlinc1 expression resulted in defection of islet development and impaired glucose homeostasis in adult mice [10] . These results suggest that lncRNAs are involved in islet cell differentiation, development processes and maintaining the function of adult β cells. Therefore, identifying additional islet-related lncRNAs and exploring their role in maintaining islet β cell function could provide new technologies and ideas for pancreatic β cell function and molecular mechanisms of diabetes.
LncRNA Gas5 (growth arrest-specific transcript 5) was originally isolated by a subtractive cDNA library [11] . lncRNA Gas5 is the key regulatory factor in mammalian cell apoptosis and growth, suggesting that lncRNA Gas5 is essential for normal growth and development. lncRNA Gas5 is extensively expressed in various tissues and organs in mice and humans. Mouse lncRNA Gas5 is located on chromosome 1, with a length of 2554 bp. Recent studies have found that human serum lncRNA Gas5 level is correlated with T2DM [12] . However, it is unclear whether lncRNA Gas5 is involved in maintaining the function of adult mouse pancreatic β cells.
This study aimed to identify the relationship between lncRNA Gas5 and the function of adult islet cells. We demonstrated that lncRNA Gas5 was highly expressed in pancreatic tissues and downregulated in T2DM mice (db/db mice). Downregulation of lncRNA Gas5 expression in vitro blocked pancreatic β cell proliferation and impaired insulin synthesis and secretion. Therefore, lncRNA Gas5 might serve as a new regulator in pancreatic β cell function and T2DM development. Pancreatic islets of C57BL/6J mice (n=20, weight, 20-25 g) and db/db mice were isolated and hand-picked according to previously described methods [3] . Primary islets were cultured in 24-well plates with complete RPMI-1640 medium (Invitrogen, Carlsbad, CA) containing 11.1 mM glucose, 10 mM HEPES supplemented with 10% fetal bovine serum, 100 units/ mL penicillin, and 100 mg/mL streptomycin for 4 h to recover from isolation prior to experimental procedures.
Cell culture and siRNA transfection
Mouse pancreatic β cell line Min6 was cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA) containing 25 mM D-glucose, 10 mM HEPES, 50 mM sodium pyruvate supplemented with 15% FBS, 100 units/mL penicillin, 100 mg/mL streptomycin, and 50 mmol/L β-mercaptoethanol at 37˚C in 5% CO 2 . lncRNA Gas5-specific small interfering RNA (siRNA) (Invitrogen, Carlsbad, CA 10650006) ( Table 1 ) and scrambled siRNA (Invitrogen, Carlsbad, CA 12935300) were designed and synthesized from Invitrogen and transfected to Min6 cells by Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). The final concentration of each siRNA in the transfection sample was 100 nmol/L, according to the manufacturer's instructions. After 48 h transfection, cells were processed for subsequent experiments. To verify if there were any off-target effects, expression of LncRNA Gas5 was examined using real-time PCR after three Gas5-siRNA mixture transfections, which could effectively avoid off-target effects.
Mouse pancreatic islets Gas5 siRNAs transfection
Pancreatic islets of C57BL/6J mice were isolated and hand-picked; Mice islets were transferred to 6-well plates (100 islets per well) and cultured in 2 ml RPMI-1640 medium for 24 h; Then, lncRNA Gas5-specific small interfering RNA (siRNA) and scrambled siRNA were transfected to isolate primary islets using Lipofectamine 2000 reagent. The final concentration of each siRNA in the transfection sample was 100 nmol/L, according to the manufacturer's instructions. After 24 h, isolated primary islets were collected for the following experiments.
Glucose treatment of Min6 cells
To study the effects of glucose exposure, Min6 cells were plated in 6 wells plates (5×10 5 per well) and then assigned to DMEM medium containing 5. 
RNA extraction and Real-time PCR analyses
Total RNA was extracted and purified from isolated mouse islets (150 islets for each batch), various tissues from mice and cultured Min6 cells using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. RNA (1μg) was reverse transcribed to cDNA in a final volume (20μL) by using a Reverse Transcription Kit (Takara, Dalian, China). Real-time PCR analyses were performed with SYBR Premix Ex Taq (Takara, Dalian, China). Mouse β-actin as an internal control gene was not affected under the glucose treatment experimental conditions. Gene expression was determined by 2 -ΔΔCt methodology, normalized against the β-actin. All the primer sequences were listed in Table 1 . qRT-PCR and data collection were presented using an ABI 7500 real-time PCR system.
Flow cytometry analysis
Min6 cells transiently transfected with lncRNA Gas5-siRNA were harvested at 48 h post-transfection by trypsinization. After double-staining with fluorescein isothiocyanate (FITC)-Annexin V and propidium iodide (PI), transfected cells were analyzed by flow cytometry (FACScan, BD Biosciences, San Jose, CA) via Cell Quest software (BD Biosciences). Cells were categorized as viable, dead, early apoptosis, and late apoptosis cells; then, the relative ratio of apoptotic cells was compared to control transfectant from each experiment. Cells for cell cycle analysis were stained with PI using the CycleTEST™PLUS DNA Reagent Kit (BD Biosciences) following the protocol and analyzed by FACScan. The percentage of cells in G0/G1, S, and G2/M phase were counted and compared.
Measurement of insulin secretion and intracellular insulin protein content
Min6 cells were planted in 48-well plates at 5×10 4 cells per well. After 48 h transfection, the medium was removed, and cells were washed twice with sterile Krebs Ringer buffer (KRB) containing 115 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 20 mM NaHCO 3 , 16 mM HEPES, 2.56 mM CaCl 2 , and 0.2% bovine serum albumin (BSA), followed by pre-incubation with 200 ml of the same buffer supplemented with 2 mM glucose at 37˚C for 1 h. Subsequently, cells were treated for 1 h in 200 µL KRB buffer containing low (2 mM) or high (20 mM) concentrations of glucose. Supernatants were collected at the indicated time, and insulin concentrations were determined using radioimmunoassay (RIA) according to previously described methods [13] . After transfection for 48 h (at 25 mM glucose), acid ethanol extraction (0.15 M HCl in 75% ethanol) occurred, and cellular insulin content was detected. These results were normalized to the total protein concentration according to previously described methods [14] . Subsequently, the amount of secreted insulin protein was counted (as a ratio) and compared with total cellular insulin content.
Protein extraction and western blot assay
Min6 cells were lysed using RIPA protein extraction reagent, supplemented with a protease inhibitor (cocktail) and phenylmethylsulfonyl fluoride (PMSF). With protein content determined, western blotting was performed according to previously described methods [15] . The primary antibodies and dilutions were anti-Pdx-1 (dilution of 1:500) and anti-MafA (dilution of 1:200), from Santa Cruz Biotechnology (CA). Target protein levels were normalized to the levels of the control protein, mouse anti-β-actin (dilution of 1:1000) from Cell Signaling Technology. The secondary antibody was horseradish peroxidase-conjugated goat antirabbit IgG (dilution of 1:5000), goat anti-mouse IgG (dilution of 1:5000), or mouse anti-goat IgG (dilution of 1:10000) from Beijing Zhong Shan Biotechnology.
Data analysis
Results are presented as the mean±SE. Comparisons were performed using Student's t-test between pairs of groups or ANOVA for more than two groups, followed by Dunnett's multiple comparison. Significance was set at P<0.05, which is indicated in the figures.
Results

lncRNA Gas5 was relatively high expressed in mouse pancreas and decreased in T2DM mouse models
We used RT-PCR to examine the expression level of lncRNA Gas5 in adult male C57BL/6J mice tissues, including heart, liver, spleen, lung, muscle, and pancreas; pancreas tissue had relatively high lncRNA Gas5 expression (Fig. 1A) . After islet isolation, lncRNA Gas5 was primarily expressed in mice pancreatic islet extracts compared to exocrine glands (Fig. 1B) .
To determine the potential role of lncRNA Gas5 in the pathogenesis of diabetes, we first examined blood glucose in 8 and 12-week-old control and T2DM mice (db/db mice) ( Fig.  2A and C) . Expression of lncRNA Gas5 was detected in 8 and 12-week-old db/db mice islets. We found that the expression of lncRNA Gas5 in db/db mice islets was less than that in the control mice (Fig. 2B and D) . These results suggest that the low expression of lncRNA Gas5 might be related to diabetes.
lncRNA Gas5 was dynamically regulated by glucose
Previous results showed that the lncRNA Gas5 level was significantly decreased when db/db mice were hyperglycemic. Thus, we speculated that decreased lncRNA Gas5 levels Cell
In vitro, Min6 cell glucose-stimulated insulin secretion (GSIS) was appropriately preserved in the presence of 25 mM glucose. We found that expression levels of lncRNA Gas5 were dynamically regulated by glucose concentrations ranging from 5.5 mM to 33.3 mM, correlating with the insulin gene (Ins2) and MafA mRNA levels ( Fig. 3A and B) . It was noted that high glucose concentration (33.3 mM) suppressed the expression level of lncRNA Gas5. Ins2 was previously reported to be regulated by glucose at the transcriptional level. MafA is a β-cell-specific and glucose-regulated transcriptional activator for insulin gene expression; thus, it might be involved in the function and development of β cells, as well as in the pathogenesis of diabetes [16, 17] . These results indicate that lncRNA Gas5 is likely to play a role in pancreatic β cell function.
Suppression of lncRNA Gas5 expression in Min6 cells induces impairment of GSIS
To determine the influence of lncRNA Gas5 on pancreatic β cell function, we used lncRNA Gas5 siRNA to downregulate lncRNA Gas5 expression and detected its effects on insulin synthesis and secretion. First, to downregulate the expression of lncRNA Gas5, lncRNA Gas5 siRNA (si-1, si-2, si-3) and a negative control sequence (si-NC) were transiently transfected into Min6 cells. Cells were collected at 48 h after transfection for detecting lncRNA Gas5 expression. RT-PCR analysis revealed that lncRNA Gas5 si-3 was the most effective, achieving approximately 50% reduction compared with si-NC (Fig. 4.1A) . The following experiments in Min6 cells and mouse pancreatic primary islets all used lncRNA Gas5 si-3 for knockdown studies.
lncRNA Gas5 siRNA and si-NC were transfected into Min6 cells. After 48 h, we performed the glucose-stimulated insulin secretion (GSIS) assay and detected insulin secretion by RIA. At 2 mM glucose concentration, no obvious differences in secreted insulin concentrations in Min6 calls were observed, whereas insulin secretion was significantly reduced in 20 mM glucose concentration in the lncRNA Gas5 siRNA-treated group (Fig. 4.1B) . Impairment of glucose-stimulated insulin secretion might result from a defect in insulin synthesis [18] . We also found a decrease in cellular insulin content in the lncRNA Gas5 siRNA-treated group (Fig. 4.1C) .
To determine the function of lncRNA Gas5 in insulin production, insulin gene transcripts Insulin1 (Ins1) and Insulin2 (Ins2) were detected by RT-PCR. Insulin2 was more abundant and was significantly reduced in the lncRNA Gas5 siRNA-treated group (Fig. 4.2A) .
To further explain how downregulated lncRNA Gas5 expression impaired insulin production, we quantified several selected transcriptional factors that are known to play a role in pancreatic β cell maturation and insulin transcription. These included pancreatic and duodenal homeobox factor 1 (Pdx1), v-maf musculoaponeurotic fibrosarcoma oncogene homologue A (MafA), neurogenic differentiation factor 1 (NeuroD1), NK6 homeobox 1 (Nkx6.1) and glucose transporter 2 (Glut2) at mRNA levels. Except for Nkx6.1, expression was significantly decreased in the lncRNA Gas5 siRNA-treated group (Fig. 4.2B) . Particularly, inhibition of lncRNA Gas5 expression selectively reduced expression of Pdx1 and MafA in mRNA and protein levels (Fig. 4.2B and C) . These results may suggest that lncRNA Gas5 could affect insulin production by regulating several key genes, specifically Pdx1 and MafA.
Effects of downregulation lncRNA Gas5 expression on mouse pancreatic β cell proliferation and apoptosis
To assess the role of lncRNA Gas5 on β cell mass, we investigated the effects of downregulated lncRNA Gas5 expression on Min6 cell proliferation and apoptosis. Flowcytometry analysis showed that downregulation of lncRNA Gas5 expression induced cell Biochemistry Fig. 6 . Expression of cell cycle protein in Min6 cells. Min6 cells were transfected with Gas5-siRNA or a negative control-siRNA using Lipofectamine2000 for 48h. mRNA levels of CyclinD1, CyclinD2, CyclinD3, CyclinE1, CyclinE2 were determined by Real-time PCR(n=3). β-actin was used as an internal control. Values are the means ± SEM of three seperate experiments. *, P<0.05;**, P<0.01 vs si-NC. cycle G1/G0 arrest; however, it had no effect on cell apoptosis of Min6 cells (Fig. 5 A and B) .
Several genes involved in cell cycle G1/G0 arrest decrease after transfection with lncRNA Gas5 siRNA. We used RT-PCR to detect expression levels of cell cycle proteins, including cyclinD1, cyclinD2, cyclinD3, cyclinE1, and cyclinE2, after transfection with lncRNA Gas5 siRNA. Data showed decreased expression of cyclin proteins (Fig. 6) . These results indicate that downregulation of lncRNA Gas5 expression might block pancreatic β cell proliferation through cell cycle G1/G0 arrest.
Downregulation of lncRNA Gas5 expression in primary islet of normal mice impairs insulin synthesis
We extracted the normal adult C57BL/6J mice islet. At the primary islet level, using Gas5 siRNAs that were transient transfected blocked lncRNA Gas5 expression, verifying the effects of insulin synthesis at the cellular level. After 48 h transfection, we detected lncRNA Gas5-siRNA interference efficiency by RT-PCR in isolated mouse islets. We found that the lncRNA Gas5 level in the lncRNA Gas5 siRNA-treatment group decreased by 70±4% compared with the control group (Fig. 7A) . Preliminary experimental results of Min6 cells confirmed that downregulation of lncRNA Gas5 expression caused lower expression of islet-specific transcription factor, leading to the decrease of synthesis and secretion of insulin. Therefore, we examined insulin gene transcription factors Insulin1 (Ins1) and Insulin2 (Ins2) and examined selected islet-specific transcription factors including Pdx1, MafA and NeuroD by RT-PCR in the lncRNA Gas5-siRNA treatment group at the mRNA level. The results showed that Ins2, Pdx1, MafA and NeuroD1 mRNA levels were reduced by 60±2%, 80±2%, 80±3%, and 50±7% (P<0.01), respectively, in the Gas5-siRNA treatment group (Fig. 7B and C) . Pdx1 and MafA decreased more significantly in the lncRNA Gas5-siRNA treatment group, consistent with previous results at the cellular level. This suggests that lncRNA Gas5 might affect insulin gene expression by affecting the expression of specific β cell transcription factors, further influencing synthesis of insulin.
Discussion
lncRNAs are involved in regulating protein-coding gene expression in the form of RNA in epigenetic, transcriptional regulation and post-transcription levels involved in cell development [19] , cell cycle [20] , cell survival, cell differentiation and other important regulation processes. lncRNAs are also involved in regulating various pathological processes, such as cancer, diabetes, autoimmune diseases and Alzheimer's disease [21, 22] . Recent studies [23] showed that the effects of the lncRNA NONRATT021972 small interfering RNA (siRNA) on dysfunction of hepatic GK through AKT signaling in T2DM rats indicated that lncRNA NONRATT021972 siRNA might have beneficial effects on T2DM. One study [24] investigated the function of β cell-specific lncRNAs and transcription factors using transcription factor knockdowns and co-expression network analysis. The results indicated that lncRNAs regulate β cell-specific transcription factor networks. Our results indicate that further study of lncRNA's role in physiological and pathological processes of organisms, as well as its its mechanism of action, not only could increase our understanding of physiological and pathological processes but also could provide new ideas and solutions for disease prevention, diagnosis, and treatment.
This study demonstrates that lncRNA Gas5 had relatively high expression in C57BL/6 mouse pancreatic tissue compared to heart, liver, spleen, lung, or muscle tissues (Fig.  1A) . This might be related to pancreatic islet function. Further, lncRNA Gas5 level was Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry significantly decreased in T2DM mice (db/db mice) compared with control mice (Fig. 2 B  and D) . Therefore, we speculated that the decreased expression of lncRNA Gas5 in T2DM mice is likely involved in pancreatic β cell mass reduction or function defect in diabetes. Glucose was a primary stimulating factor for maintaining pancreatic β cell function, which can regulate insulin gene expression and biosynthesis [25] . Dysfunction of pancreatic β cells played an important role in the pathogenic process of T1DM and T2DM. Insulin biosynthesis was regulated at the transcription and translation level [26] . The β cell ability of rapid response to intracellular signals was mainly due to transcriptional regulation. The numerous discrete sequence elements in insulin gene promoter regions were named the A, C, E, Z and CRE elements, which determined the location of β cell insulin and provided binding sites for several types of β cell transcription factors that regulate insulin gene expression [27] . Islet-specific transcription factors Pdx1, MafA and NeuroD1 can combine with insulin gene promoter regions, regulating insulin gene transcription and thus affecting the synthesis and secretion of insulin. In this study, we used small interference RNA to knockdown expression of lncRNA Gas5 at the cell line and primary islet levels, and we detected its effect on pancreatic β cell function. The results showed reduced biosynthesis and secretion of insulin. Isletspecific transcription factors and glucose transporter GLUT2, which are related to insulin secretion mRNA levels, were also reduced. Pdx1 and MafA were significantly decreased at the mRNA and protein levels. Pdx1 plays an important role in pancreas development and adult β cell function. Studies showed that [28] in the pancreas, MafA was specifically expressed in mature β cells. Islet transcriptome analysis, after MafA knockout, revealed that MafA was necessary for several β cell-related key molecules, such as Glut2 and CyclinD2. GLUT2 primarily exists in the liver, small intestine, kidney, and pancreatic islet β cells. In islet β cells, GLUT2 is necessary to stimulate insulin secretion of glucose [29] . From this, we conclude that lncRNA Gas5 affected insulin synthesis processes through insulin gene and islet-specific transcription factor regulation and could also influence the course of insulin secretion via glucose transporter regulation.
LncRNA Gas5 was the key regulatory factor of mammalian cell apoptosis and growth. In this study, we demonstrated that downregulation of lncRNA Gas5 expression resulted in cell cycle G1 arrest in pancreatic Min6 β cell lines. Previous studies [30] showed that cyclinD2 was a key factor in β cell proliferation in normal postnatal mice. CyclinD2 was necessary for adult mice glucose metabolism and normal postnatal islet growth. CyclinD3 or E cycle protein in β cell development could compensate for CyclinD2 and D1 [31] . In this study, we found that inhibition of lncRNA Gas5 expression in Min6 cells could make cyclinD1, cyclinD2, cyclinD3, cyclinE1, and cyclinE2 mRNA levels decrease. Among these, CyclinD1 and CyclinD2 were significantly reduced. This suggests that downregulation of lncRNA Gas5 expression in Min6 cells caused pancreatic β cell cycle G1 phase arrest, which might be mediated by D-cell cycle protein pathways. Further studies are needed to determine mechanisms for regulating the cell cycle.
Conclusion
We report for the first time that lncRNA Gas5 may play a role in regulating pancreatic β cell function. In addition, this study identified lncRNA Gas5 as a novel regulator of insulin synthesis and secretion in pancreatic β cells. We demonstrated that the expression of lncRNA Gas5 decreased in T2DM mice, suggesting that lncRNA Gas5 might be involved in pathogenesis of T2DM. It should be noted that inhibition of lncRNA Gas5 affected insulin production by decreasing the expression of islet-specific transcription factors, including Pdx1 and MafA. Therefore, downregulation of lncRNA Gas5 because of hyperglycemia might partly bring about β cell dysfunction and could be involved in diabetes pathogenesis. In the future, lncRNA Gas5 could be used as a new target for the diagnosis and research of diabetes.
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